Jiang Yi, Xu Bing-Hong, Rodgers Brandon, Pyrsopoulos Nikolaos
Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Liver Center & Center for Asian Health, RWJBH-Saint Barnabas Medical Center, Florham Park, New Jersey, USA.
J Clin Transl Hepatol. 2021 Jun 28;9(3):392-398. doi: 10.14218/JCTH.2021.00008. Epub 2021 Mar 11.
Primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) are hepatobiliary diseases of presumed immune-mediated origin that have been shown to overlap. The aim of this retrospective trial was to use national data to examine the characteristics and outcomes of patients hospitalized with overlapping PBC and AIH (PBC/AIH).
The National Inpatient Sample was used to identify hospitalized adult patients with PBC, AIH, and PBC/AIH from 2010 to 2014 by International Classification of Diseases-Ninth Edition Revision codes; patients with hepatitis B virus and hepatitis C virus infection were excluded. Primary outcomes measures were in-hospital outcomes that included mortality, respiratory failure, septic shock, length of stay, and total hospital charges. Secondary outcomes were the clinical characteristics of PBC/AIH, including the comorbid extrahepatic autoimmune disease pattern and complications of cirrhosis.
A total of 3,478 patients with PBC/AIH were included in the study. PBC/AIH was associated with higher rates of Sjögren's syndrome (<0.001; <0.001), lower rates of Crohn's disease (<0.05; <0.05), and higher rates of cirrhosis-related complications when compared to PBC or AIH alone. There were similar rates of mortality between the PBC/AIH, PBC, and AIH groups. The PBC/AIH group had higher rates of septic shock when compared to the PBC group (<0.05) and AIH group (<0.05) after adjusting for possible confounders.
PBC/AIH is associated with a lower rate of Crohn's disease, a higher rate of Sjögren's syndrome, higher rates of cirrhosis-related complications, and significantly increased risk of septic shock compared to PBC and AIH individually.
原发性胆汁性胆管炎(PBC)和自身免疫性肝炎(AIH)是推测由免疫介导的肝胆疾病,已显示二者存在重叠。这项回顾性试验的目的是利用全国数据研究重叠性PBC和AIH(PBC/AIH)住院患者的特征及转归。
使用全国住院患者样本,通过国际疾病分类第九版修订本编码,识别2010年至2014年住院的成年PBC、AIH及PBC/AIH患者;排除乙型肝炎病毒和丙型肝炎病毒感染患者。主要结局指标为住院结局,包括死亡率、呼吸衰竭、感染性休克、住院时间及总住院费用。次要结局为PBC/AIH的临床特征,包括合并的肝外自身免疫性疾病模式及肝硬化并发症。
本研究共纳入3478例PBC/AIH患者。与单独的PBC或AIH相比,PBC/AIH与干燥综合征发生率较高(<0.001;<0.001)、克罗恩病发生率较低(<0.05;<0.05)及肝硬化相关并发症发生率较高相关。PBC/AIH组、PBC组和AIH组之间的死亡率相似。在调整可能的混杂因素后,PBC/AIH组与PBC组(<0.05)和AIH组(<0.05)相比,感染性休克发生率较高。
与单独的PBC和AIH相比,PBC/AIH与较低的克罗恩病发生率、较高的干燥综合征发生率、较高的肝硬化相关并发症发生率及感染性休克风险显著增加相关。